The objectives of the study are to determine:
- Oncology patients’ experiences of breakthrough pain.
- Oncology patients’ experiences of breakthrough pain medication.
- Oncology patients’ views about forthcoming breakthrough medications.
Associate Professor Odette Spruyt
International lead: Dr Andrew Davies
Royal Marsden Hospital, Surrey, UK.
Peter Mac Principal Investigator: A/Prof Odette Spruyt
A/Prof Odette Spruyt
Email: [email protected]
Publications & presentations
Davies, A.Zeppetella, G.Andersen, S. et al 2011. Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain 15(7);756-63
Spruyt, O. Philip, J. Characterisation of breakthrough pain in an Australian cohort of cancer patients. MASCC 2016 e-poster (in progress)